Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
2.
BMC Med Imaging ; 22(1): 111, 2022 06 11.
Article in English | MEDLINE | ID: mdl-35690733

ABSTRACT

BACKGROUND: Interpretation of Low Dose CT scans and protocol driven management of findings is a key aspect of lung cancer screening program performance. Reliable and reproducible methods are needed to communicate radiologists' interpretation to the screening program or clinicians driving management decision. METHODS: We performed an audit of a subset of dictated reports from the PANCAN study to assess for omissions. We developed an electronic synoptic reporting tool for radiologists embedded in a clinical documentation system software. The tool was then used for reporting as part of the Alberta Lung Cancer Screening Study and McGill University Health Centre Pilot Lung Cancer Screening Program. RESULTS: Fifty reports were audited for completeness. At least one omission was noted in 30 (70%) of reports, with a major omission (missing lobe, size, type of nodule in report or actionable incidental finding in recommendation section of report) in 24 (48%). Details of the reporting template and functionality such as automated nodule cancer risk assessment, Lung-RADS category assignment, auto-generated narrative type report as well as personalize participant results letter is provided. A description of the system's performance in its application in 2815 CT reports is then summarized. CONCLUSIONS: We found that narrative type radiologist reports for lung cancer screening CT examinations frequently lacked specific discrete data elements required for management. We demonstrate the successful implementation of a radiology synoptic reporting system for use in lung cancer screening, and the use of this information to drive program management and communications.


Subject(s)
Early Detection of Cancer , Lung Neoplasms , Electronics , Humans , Lung Neoplasms/diagnostic imaging , Thorax , Tomography, X-Ray Computed/methods
3.
J Am Coll Radiol ; 16(10): 1425-1432, 2019 Oct.
Article in English | MEDLINE | ID: mdl-31103442

ABSTRACT

BACKGROUND: False-positive scans and resultant needless early recalls can increase harms and reduce cost-effectiveness of low-dose CT (LDCT) lung cancer screening. How LDCT scans are interpreted and classified may impact these metrics. METHODS: The Pan-Canadian Early Detection of Lung Cancer risk calculator was used to determine nodule risk of malignancy on baseline screening LDCTs in the Alberta Lung Cancer Screening Study, which were then classified according to Nodule Risk Classification (NRC) categories and ACR Lung Screening Reporting and Data System (Lung-RADS). Test performance characteristics and early recall rates were compared for each approach. RESULTS: In all, 775 baseline screens were analyzed. After a mean of 763 days (±203) of follow-up, lung cancer was detected in 22 participants (2.8%). No statistically significant differences in sensitivity, specificity, or area under the receiver operator characteristic curve occurred between the NRC and Lung-RADS nodule management approaches. Early recall rates were 9.2% and 9.3% for NRC and Lung-RADS, with the NRC unnecessarily recalling some ground glass nodules, and the Lung-RADS recalling many smaller solid nodules with low risk of malignancy. CONCLUSION: Performances of both the NRC and Lung-RADS in this cohort were very good with a trend to higher sensitivity for the NRC. Early recall rates were less than 10% with each approach, significantly lower than rates using the National Lung Screening Trial cutoffs. Further reductions in early recall rates without compromising sensitivity could be achieved by increasing the NRC threshold to 20% for ground glass nodules or by applying the nodule risk calculator with a 5% threshold to 6- to 10-mm solid nodules under Lung-RADS.


Subject(s)
Early Detection of Cancer , Lung Neoplasms/diagnostic imaging , Tomography, X-Ray Computed , Aged , Aged, 80 and over , Alberta/epidemiology , Canada/epidemiology , Data Systems , Female , Humans , Lung Neoplasms/epidemiology , Male , Mass Screening , Middle Aged , Risk Assessment
4.
AJR Am J Roentgenol ; 194(5): W407-13, 2010 May.
Article in English | MEDLINE | ID: mdl-20410386

ABSTRACT

OBJECTIVE: Renal allograft function monitoring has traditionally relied on functional markers such as creatinine level. Such markers are insensitive, and invasive ultrasound-guided protocol biopsies are used for allograft evaluation. This pilot study evaluates the association between renal perfusion measured noninvasively with contrast-enhanced MRI and the histologic severity of chronic allograft nephropathy. SUBJECTS AND METHODS: Chronic allograft nephropathy severity was estimated from protocol biopsy specimens using the chronic allograft damage index. We prospectively selected four patients considered to have severe chronic allograft nephropathy (chronic allograft damage index score > 4) and six patients considered to have stable allograft function (chronic allograft damage index score 4 than in the other patients (1.94 vs 2.43 mL/min/g, respectively; p = 0.03). The effect size for this difference was large (d = 1.7). The R(2) for the linear regression model was 0.53. CONCLUSION: We observed an association between contrast-enhanced MRI renal perfusion and chronic allograft nephropathy severity. Further studies are needed to confirm this preliminary finding and to evaluate the role of contrast-enhanced MRI renal perfusion as a screening test for allograft dysfunction and potential utility in patient management.


Subject(s)
Gadolinium DTPA , Glomerulonephritis, Membranous/diagnosis , Glomerulonephritis, Membranous/etiology , Graft Rejection/diagnosis , Graft Rejection/etiology , Kidney Transplantation/adverse effects , Magnetic Resonance Angiography/methods , Adult , Chronic Disease , Contrast Media , Female , Humans , Image Enhancement/methods , Male , Middle Aged , Perfusion Imaging/methods , Pilot Projects , Reproducibility of Results , Sensitivity and Specificity
5.
J Magn Reson Imaging ; 20(2): 193-200, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15269943

ABSTRACT

PURPOSE: To compare isotropic (combined diffusion-weighted image [CMB], apparent diffusion coefficient [ADC], TRACE, exponential ADC [eADC], and isotropically-weighted diffusion image [isoDWI]) and anisotropic (relative anisotropy [RA], fractional anisotropy [FA], and volume ratio [VR]) diffusion images collected with fast magnetic resonance (MR) diffusion-weighted (DWI) and diffusion-tensor (DTI) acquisition strategies (each less than one minute) in hyper-acute stroke. MATERIALS AND METHODS: Twenty-one patients suffering from ischemic stroke-imaged within six hours of symptom onset using both DWI and DTI-were analyzed. Regions of interest were placed in the ischemic lesion and in normal contralateral tissue and the percent difference in image intensity was calculated for all nine generated images. RESULTS: The average absolute percent changes for the isotropic strategies were all > 38%, with isoDWI found to have a difference of 50.7% +/- 7.9% (mean +/- standard error, P < 0.001). The ADC maps had the most significant difference (-42.4% +/- 2.0%, P < 0.001, coefficient of variation = 0.22). No anisotropic images had significant differences. CONCLUSION: Anisotropic maps do not consistently show changes in the first six hours of ischemic stroke; therefore, isotropic maps, such as those obtained using DWI, are more appropriate for detecting hyper-acute stroke. Anisotropic images, however, may be useful to differentiate hyper-acute stroke from acute and sub-acute stroke.


Subject(s)
Diffusion Magnetic Resonance Imaging/methods , Image Processing, Computer-Assisted/methods , Stroke/diagnosis , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Plasminogen Activators/therapeutic use , Severity of Illness Index , Stroke/drug therapy , Tissue Plasminogen Activator/therapeutic use
6.
J Magn Reson Imaging ; 15(5): 591-6, 2002 May.
Article in English | MEDLINE | ID: mdl-11997901

ABSTRACT

PURPOSE: To examine the effect of varying the diffusion encoding strength (b value) on the contrast (signal difference, Delta S) between damaged and normal tissue during diffusion-weighted magnetic resonance imaging (DWI) assessment of acute ischemic stroke. MATERIALS AND METHODS: Phantoms with diffusion values approximating those expected in acutely infarcted and normal tissue were constructed from a mixture of agar and formaldehyde and imaged at varying b values (0-3000 mm(-2) second). Ten patients were imaged with multiple b values (500-2500 mm(-2) second) within 12 hours of stroke onset. RESULTS: Theoretical calculations showed that for any combination of diffusion coefficients there existed an optimal b value that was higher than the standard setting of 1000 mm(-2) second, and this was confirmed by the phantom studies. In the patients, increasing b from 1000 to 1500 mm(-2) second increased Delta S (average, 22.4%; P = 0.001), but no consistent benefit was seen at b = 2000 mm(-2) second (P = 0.408). This compared favorably with the average optimal b value of 1662 mm(- 2) second calculated from the patients. CONCLUSION: These results suggest that increasing the b value from 1000 to 1500 mm(-2) second would increase contrast between infarcted and normal tissue in the setting of acute ischemic stroke.


Subject(s)
Brain Ischemia/pathology , Magnetic Resonance Imaging/methods , Acute Disease , Adult , Aged , Analysis of Variance , Diffusion , Female , Humans , Male , Middle Aged , Phantoms, Imaging
SELECTION OF CITATIONS
SEARCH DETAIL
...